Evidence map›Paper›PMID 40298643›Full record

ReviewAntioxidants (Basel, Switzerland)2025

Natural Compounds with Beneficial Effects on Skin Collagen Type I and Mechanisms of Their Action.

Wioleta Żynda, Agnieszka Ruczaj, Anna Galicka

Abstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Pharmaceutical biology · 2026
    Article
  2. Antioxidants (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Evaluation ofMedical sciences (Basel, Switzerland) · 2026
    Article
  5. Mandelamide Isolated fromBiomolecules · 2026
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wioleta ŻyndaDepartment of Medical Chemistry, Medical University of Bialystok, ul. Mickiewicza 2A, 15-222 Bialystok, Poland.
Agnieszka RuczajDepartment of Medical Chemistry, Medical University of Bialystok, ul. Mickiewicza 2A, 15-222 Bialystok, Poland.ORCID 0000-0003-0259-8344
Anna GalickaDepartment of Medical Chemistry, Medical University of Bialystok, ul. Mickiewicza 2A, 15-222 Bialystok, Poland.ORCID 0000-0002-4027-989X

Funding

Medical University of Białystok B.SUB.24.310Medical University of Białystok, Poland B.SUB.24.310
6 · The paper itself

Abstract

The skin, as the largest external organ, is exposed to many environmental factors, such as sunlight and pollution, as well as some synthetic ingredients in cosmetic products used in excess by most people of all ages throughout their lives. Under the influence of these factors and with age, the amount of the key building protein, collagen type I, decreases, which leads to a deterioration in the appearance and condition of the skin. Currently, when the average life expectancy increases, the esthetic aspect and maintaining healthy skin are particularly important. In the cosmetic and pharmaceutical industries, attempts have long been made to prevent skin aging by the application of products containing natural compounds, mainly due to their high antioxidant activity. This review collects natural compounds, mainly polyphenols, with stimulating and protective effects on collagen type I in human skin fibroblasts, along with a description of the mechanisms of their action. Some of them have been tested on mice and rats, as well as in clinical trials, and in most cases, the results have been very promising. Nevertheless, there is still a need for an intensification of clinical studies in order to determine their appropriate dosage, safety, and effectiveness.

Indexed as

agingcollagen type Ifibroblastspolyphenolsskin

Identifiers

PMID40298643
PMCPMC12024060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.